The number of patients with both type 2 diabetes and dementia is rising, which poses new challenges in blood glucose monitoring and medicines administration
Diabetes and dementia may manifest simultaneously: one is potentially life threatening, the other causes severe, progressive loss of memory and cognitive function. Where they coexist, they present nurses with challenges such as administering life-saving interventions to patients who are unable to give informed consent. This article offers guidance on the clinical and ethical challenges involved in blood glucose monitoring and medicines administration in patients with dementia.
Citation: Brown J et al (2014) Managing diabetes in people with dementia. Nursing Times; 111: 10, 16-19.
Authors: Joe Brown is lecturer in nursing; Amanda Carson is lecturer in adult nursing; Anna Waugh is lecturer in mental health nursing; Douglas Park is senior librarian; all are at the University of the West of Scotland, Dumfries.
- This article has been double-blind peer reviewed
- Scroll down to read the article or download a print-friendly PDF here
The incidence of both diabetes and dementia is rising, and nurses in all settings are increasingly likely to encounter patients who have both conditions.
The coexistence of the two can have enormous consequences – complications from one condition having a significant effect on the course of the other (Trend-UK and Institute of Diabetes for Older People, 2013). For example, some signs and symptoms of diabetes can be confused with those of dementia and treated as such, while the diabetes is neglected.
That diabetes is a direct causal factor of dementia remains unproven (Alzheimer Society Canada, 2014; Peila et al, 2002; Curb et al, 1999; Ott et al, 1996). However, Exalto et al (2013) point out that people who have type 2 diabetes are twice as susceptible to dementia than those who do not. Where these two conditions manifest simultaneously, they present nurses with daily clinical and ethical challenges. The need to administer life-saving interventions to patients who may not understand and are unable to give informed consent, while adhering to professional and personal standards of care, and preservation of life against the ethical principles of consent and non-maleficence.
Type 2 diabetes
The incidence of type 2 diabetes is rising because of changing lifestyles and increasing longevity. Contributory factors include a diet rich in sugar and fats, poor exercise regimes and obesity. However, with early diagnosis and treatment, people are living with diabetes into old age.
Type 2 diabetes is most common in older adults, and in adults from African-Caribbean and South Asian communities. Almost 3 million people in the UK have a diagnosis of type 2 diabetes, which accounts for 90% of all cases of diabetes. It is estimated a further 850,000 cases remain undiagnosed. The prevalence of diabetes could nearly double in the next decade to affect 5% of the UK population without preventive measures (Trend-UK and IDOP, 2013; Diabetes UK, 2012).
Diabetes is a chronic rise in the body’s blood glucose concentration, because glucose is not absorbed into the body’s cells.
Insulin acts as a regulator of blood glucose (Williams and Pickup, 2005) and is produced by the pancreas. In diabetes, either the pancreas produces less insulin than is needed, or the insulin it produces is unable to work in its normal manner – for example because of excess body fat – this is called insulin resistance. Exercise, a controlled diet and oral medication can allay the problems associated with type 2 diabetes.
Common signs and symptoms include:
- Polyuria caused by passing large amounts of urine;
- Genital itching and urinary tract infections caused by increased bacteria;
- Delayed wound healing;
- Lethargy and fatigue because of a lack of energy;
- Weight loss;
- Visual problems.
However, people with type 2 diabetes may have no signs or symptoms that cause them to seek medical assistance.
Longer-term complications associated with diabetes include cardiac problems, strokes, visual problems, kidney failure and limb amputations. These have profound effects on people with dementia, leading to further deterioration in both conditions and increasing the risk of falls, immobility, communication decline and foot ulcers with a prolonged healing process (Diabetes UK, 2012; Holt and Kumar, 2010; Dunning, 2009).
Dementia affects one in 20 people aged 65 years and over in the UK and one in five of those above 80 (Alzheimer’s Society, 2013). Almost 700,000 people have a diagnosis of dementia in the UK (Department of Health, 2013), but the Alzheimer’s Society (2013) suggests that almost 50% of those with dementia have no formal diagnosis. The incidence of the condition is also increasing and is expected to have doubled by 2033 (Alzheimer Scotland, 2013)
“Dementia” is an umbrella term that describes a group of symptoms caused by a variety of diseases that affect the brain. Its main causes are discussed below.
This is caused by proteins and plaques that destroy brain cells. Once gone, they cannot be replaced. The area in which cell death occurs determines the outward signs and symptoms. There is also a reduction in neurotransmitters.
Alzheimer’s is a progressive disease. Its rate of progression varies from one individual to another and, as it progresses, the symptoms become more severe. There is no cure, and the condition typically leads to death. Common signs and symptoms include confusion, memory loss, disorientation, labile moods, frustration, withdrawal and isolation.
This is caused by small bleeds throughout the brain leading to brain neuron death and damage, or by blood being unable to reach areas of the brain, resulting in hypoxia and the death of brain cells.
Affecting men more than women, vascular dementia has a stepped progression, often plateauing before worsening as it progresses. It can be managed using medication and through lifestyle changes but cannot be reversed. The condition may stabilise as a result of medication and lifestyle changes but, if its progress is not halted, it leads to death. Common signs and symptoms include cognitive deterioration, memory loss, disorientation, changes in behaviour and labile moods.
Dementia with Lewy bodies
In this type of dementia, proteins (bodies) form in the brain, leading to the death of brain cells. Dementia with Lewy bodies is a progressive degenerative condition without cure that leads to death. In addition to the symptoms associated with Alzheimer’s disease, patients may experience visual hallucinations, Parkinson’s disease signs/symptoms and fluctuations in alertness and concentration.
Nursing management of diabetes aims to reduce and counter the long-term complications of diabetes by educating patients to manage the condition independently.
This includes regular blood monitoring, ensuring that dietary and hydration needs are met, exploring lifestyles and administering when necessary oral medication and insulin in appropriate dosages at appropriate times (Hairon, 2008). Patients with type 1 diabetes and some type 2 need to measure their blood glucose at regular intervals throughout the day to ensure their blood glucose levels remain within their individual targets, to meet needs throughout the day and to minimise any risk of hypo- or hyperglycaemic attack (Table 1, attached).
Holt and Kumar (2010) suggest many people with type 2 diabetes understand the risks and recognise the signs of both hypoglycaemic and hyperglycaemic states and can act to regulate and stabilise these independently. Within clinical settings, it is the nurse’s responsibility to ensure patients have adequate levels of hydration, and appropriate nutrition – with input from a dietitian if needed – and that blood glucose targets are set for the individual and routinely monitored. This role extends to educating the patient’s family or carers.
When possible, patients manage their diabetes in clinical settings, supported or facilitated by nurses (Dunning, 2009). Where patients cannot manage by themselves, nurses should provide an appropriate level of assistance and support.
Similarly, caring for people with dementia focuses on recovery and person-centred care, promoting independence, autonomy and self-determination for as long as is safe and feasible, and taking into account predetermined plans where longer-term care is necessary (Scottish Intercollegiate Guidelines Network, 2006).
Independence and autonomy in diabetes management can be helped with aids such as dosette boxes, pharmacy-prescribed blister packs and memory aids such as alarms that prompt patients when medications are due. People with dementia should be assisted to maintain their optimum level of living, which will depend on the level of their dementia, the path it takes and their support network.
Managing both illnesses simultaneously can pose particular challenges for nursing care (Box 1). As the dementia progresses, and cognition and memory decline, management of diabetes will require increased input by nurses. Symptoms such as confusion – common in dementia and hypoglycaemia – must be accurately assessed and correctly treated.
Trend-UK and IDOP (2013) encourage the early diagnosis of dementia in people with type 2 diabetes, so regular assessments and reviews can be carried out to minimise the potential for damage.
Box 1. Tips for nursing patients with both diabetes and dementia
- Spend time discussing with patients (and families) their concerns or preferences in relation to their diabetes, and move to incorporate nursing care to meet these as appropriate
- Communicate with members of the multidisciplinary team that a patient has type 2 diabetes and dementia. The care plan should reflect this
- Help patients who carry out blood glucose monitoring to interpret results and encourage autonomous decision making where possible
- Foster independence in maintaining stable blood glucose – for example, when using insulin
- Ascertain and maintain patients’ nutritional preferences and routines
- Monitor hydration and nutrition
- Site inpatients in an en suite room or near toilet facilities because of frequent micturition. This will also reduce episodes of incontinence and resulting distress and minimise risk of falls
- Ensure patients are seen by an optician if they have not been recently. Where spectacles are required, ensure these are clean and to hand
- The use of neuroleptic medication must be carefully considered as it may greatly exacerbate the drowsiness that people with type 2 diabetes often experience
- Routine assessment of patients’ extremities should be carried out, paying particular attention to the feet and toes
Sources: Trend-UK and IDOP (2013); Dunning (2009); Metcalfe (2005); Williams and Pickup (2005)
Blood glucose monitoring
To monitor diabetes and calculate the dose of medication or insulin needed to maintain health and wellbeing, blood glucose monitoring is essential. It can take the form of a blood glucose meter test, a fasting venous blood sample or a glycated haemoglobin (HbA1c) test. Where patients can give informed consent and the nurse is satisfied they understand the procedure, he or she should follow standard procedures in accordance with local policy.
The National Institute for Health and Care Excellence (2010) recommends that, in addition to blood glucose monitoring, the following regular checks are made:
- Blood pressure;
- Cholesterol level;
- Retinal screening;
- Foot and leg check;
- Kidney function testing (urine);
- Kidney function testing (blood);
- Smoking status check.
In addition, Trend-UK and IDOP (2013) recommend regular screening for patients who are 65 years of age with type 2 diabetes, using a recognised dementia screening tool such as the Mini-Cog test.
All the above interventions require consent and co-operation from the patient.
Consent in diabetes and dementia
Consent remains a priority and must to be obtained to monitor and treat the diabetes. However, this may not be forthcoming as patients may not understand the procedure or the nurse may be unsure of the patient’s comprehension, negating informed consent even when patients give it verbally (Royal College of Nursing, 2011). Patients may also be unable to co-operate with required procedures due to memory or cognitive issues, or fear or pain. Consideration should also be given to potential communication difficulties, sensory deficits, arthritic joints and issues with mobility.
Seeking and gaining consent when any nursing interventions are undertaken should be a routine part of nurses’ practice (Nursing and Midwifery Council, 2013). Where consent is denied, nurses must respect this, provided the patient understands the consequences.
When patients with diabetes also have dementia, it is imperative to discuss the situation with the patient and family to identify how procedures may have been conducted in the past, as patients may accept specific regimens for blood glucose monitoring and insulin administration. However, it may be that consent and concordance cannot be achieved because of communication or cognitive issues.
Where adults do not have the capacity to consent, nurses may, in emergencies, administer treatment if this would save the patient’s life or prevent deterioration in their condition, provided that the nurse does not know of any just reason not to do this (such as religious convictions or a recorded advance decision/directive).
For non-emergency treatment of an adult who does not have capacity to consent, different rules apply. In Scotland, the Adults with Incapacity (Scotland) Act 2000 (Scottish Government, 2010) requires a certificate of incapacity with a treatment plan to accompany it. In England and Wales, the Mental Capacity Act (2005) allows practitioners to act in the best interests of the person with incapacity, taking into account the individual’s past and present wishes and feelings.
Consideration must be given to minimise the number of blood glucose tests required and, if insulin is required, the type of insulin given so the number of injections is minimised (Box 2).
Box 2. Types of insulin
- Rapid-acting analogues: injected just before food and have a peak action at between 0 and 3 hours
- Long-acting analogues: tend to be injected once or twice a day to provide background insulin lasting approximately 24 hours. They do not need to be taken with food because they do not have a peak action
- Very long-acting analogues: mainly used by people who are unable to inject themselves, as they can provide background insulin for up to 42 hours (although they are usually injected once a day). They do not have a peak action
- Short-acting insulins: Injected 15-30 minutes before a meal to cover the rise in blood glucose levels that occurs after eating. They have a peak action of 2-6 hours
- Medium- and long-acting insulins: are taken once or twice a day to provide background insulin or in combination with short-acting insulins/rapid-acting analogues. Their peak activity is between 4 and 12 hours and can last up to 30 hours
- Mixed insulin: a combination of medium- and short-acting insulin
- Mixed analogue: a combination of medium-acting insulin and rapid-acting analogue
Source: Diabetes UK (2015)
Following discussion with members of the multidisciplinary team and, where possible, family, covert medication may have to be considered (NMC, 2013). As a very last resort, minimum-force restraint for the shortest possible time to carry out a procedure in accordance with local and national policies may have to be considered. This must be reviewed on a regular basis in accordance with local policies.
Every time blood testing or medication is given, patients should have the procedure explained and their consent sought (as dementia can cause fluctuations in cognition), and the procedure should be recorded (NMC, 2013).
The patient’s fluid and nutritional intake must be monitored and recorded continuously to avoid hypo-glycaemic or hyperglycaemic attacks as the patient may not be able to communicate about physical changes or effects from medications.
Underpinning this process is good communication with the patient, their family and members of the multidisciplinary team to minimise any use of covert administration of medicine or restraint.
The prevalence of comorbidity is likely to rise. The competing and overlapping needs of each illness must not, however, be allowed to detract from providing person-centred care and the expectations of professionalism, and policy and protocol must be adhered to at all times regardless of the capacity of the patient concerned.
The challenge for nurses is to assess and monitor the signs and symptoms of diabetes while assessing the progress of dementia, and ensuring patients’ immediate specific and individual needs are met. Planning for the future should be regularly reviewed because of the long-term nature of the conditions.
- The incidence of diabetes could nearly double in the next decade, to affect 5% of the population
- Nearly 700,000 people have a diagnosis of dementia and as many again may be undiagnosed
- People with type 2 diabetes are twice as susceptible to dementia as those without
- Symptoms such as confusion should be assessed to determine their cause
- Nurses should consider dementia screening for people with diabetes aged over 65
Alzheimer’s Society (2013) Dementia 2013: the Hidden Voice of Loneliness.
Alzheimer Society Canada (2014) Diabetes and Dementia – is There a Connection?
Alzheimer Scotland (2013) Statistics: Number of People with Dementia in Scotland 2014.
Curb JD et al (1999) Longitudinal association of vascular and Alzheimer’s dementias, diabetes and glucose tolerance. Neurology; 52: 971-975.
Department of Health (2013) Improving Care for People With Dementia.
Diabetes UK (2012) Diabetes in the UK 2012: Key Statistics on Diabetes.
Diabetes UK (2015) Diabetes treatment
Dougherty L, Lister S (2011) Procedure guideline 13.9 blood glucose monitoring. In: The Royal Marsden Manual of Clinical Nursing Procedures. Chichester: Wiley.
Dunning T (2009) Care of People with Diabetes: a Manual of Nursing Practice. Oxford: Wiley-Blackwell.
Exalto LG et al (2013) Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. The Lancet Diabetes and Endocrinology; 1: 183-190.
Hairon N (2008) Managing type 2 diabetes with emphasis on patient education. Nursing Times; 104: 17-18.
HM Government (2005) Mental Capacity Act 2005.
Holt T, Kumar S (2010) ABC of Diabetes. Oxford: Wiley-Blackwell.
Metcalfe J (2005) The management of patients with long-term conditions. Nursing Standard; 19; 53-60.
National Institute for Health and Care Excellence (2010) The Management of Type 2 diabetes.
Nursing and Midwifery Council (2013) Covert Administration of Medicines.
Ott A et al (1996) Association of diabetes and dementia: the Rotterdam Study. Diabetologia; 39: 1392-1397.
Peila R et al (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes; 51: 1256-1262.
Royal College of Nursing (2011) Informed Consent in Health and Social Care Research.
Scottish Intercollegiate Guidelines Network (2006) Management of Patients with Dementia: 86. Edinburgh: SIGN.
Scottish Government (2010) Adults with Incapacity (Scotland) Act 2000: Code of Practice (Third Edition).
Trend-UK and Institute of Diabetes for Older People (2013) Diabetes and Dementia – Guidance on Practical Management.
Williams G, Pickup JC (2005) Handbook of Diabetes. Oxford: Blackwell.